Claudia Götz Staehelin's practice focuses on complex investigation and litigation matters at the intersection of civil, criminal and regulatory proceedings. Claudia leads large-scale internal investigations, supports her clients in crisis management and advises them on all aspects of their compliance framework. She represents and advises her clients in domestic and cross-border litigations, in international judicial and administrative assistance matters and in internal and regulatory investigations led by Swiss and foreign authorities. One of her industry focuses is the Healthcare & Life Sciences industry, where she advises clients on pharma regulatory and all compliance matters.
Based on her experience as former Head of Litigation at Novartis, Claudia regularly supports companies with multi-jurisdictional projects requiring innovative thinking. She has extensive international experience in litigation and investigation risk assessment, and in assisting clients with strategic decision-making. Her many years in-house and with corporate investigations have given her a deep understanding of the challenges and opportunities of ESG issues for companies.
Claudia is listed by Chambers & Partners and by Legal 500 as one of Switzerland's leading business lawyers in the areas of Healthcare and Life Sciences as well as Regulatory, Investigations and Compliance. Legal 500 2023 lists her as “Leading Individual” for Regulatory, Compliance & Investigation and for Healthcare & Life Sciences.